294 related articles for article (PubMed ID: 23067911)
1. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
[TBL] [Abstract][Full Text] [Related]
2. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment.
Kanoupakis EM; Manios EG; Kallergis EM; Mavrakis HE; Goudis CA; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
J Am Coll Cardiol; 2010 Jun; 55(24):2753-9. PubMed ID: 20538169
[TBL] [Abstract][Full Text] [Related]
3. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
[TBL] [Abstract][Full Text] [Related]
4. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
5. Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction.
Blangy H; Sadoul N; Dousset B; Radauceanu A; Fay R; Aliot E; Zannad F
Europace; 2007 Sep; 9(9):724-9. PubMed ID: 17526509
[TBL] [Abstract][Full Text] [Related]
6. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.
Kaye DM; Khammy O; Mariani J; Maeder MT
Eur J Heart Fail; 2013 Mar; 15(3):292-8. PubMed ID: 23143794
[TBL] [Abstract][Full Text] [Related]
7. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
[TBL] [Abstract][Full Text] [Related]
8. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
9. Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies.
Arnaldo FJ; Anatoliotakis N; Palacio C; Nabert DR; Hsu SS
Heart Lung; 2009; 38(1):10-6. PubMed ID: 19150526
[TBL] [Abstract][Full Text] [Related]
10. Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.
Kupari M; Laine M; Turto H; Lommi J; Werkkala K
J Heart Valve Dis; 2013 Mar; 22(2):166-76. PubMed ID: 23798204
[TBL] [Abstract][Full Text] [Related]
11. Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?
Collier P; Watson CJ; Voon V; Phelan D; Jan A; Mak G; Martos R; Baugh JA; Ledwidge MT; McDonald KM
Eur J Heart Fail; 2011 Oct; 13(10):1087-95. PubMed ID: 21719449
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
[TBL] [Abstract][Full Text] [Related]
13. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.
Lebedev DA; Lyasnikova EA; Vasilyeva EY; Babenko AY; Shlyakhto EV
J Diabetes Res; 2020; 2020():6976153. PubMed ID: 33224989
[TBL] [Abstract][Full Text] [Related]
14. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
Plaksej R; Kosmala W; Frantz S; Herrmann S; Niemann M; Störk S; Wachter R; Angermann CE; Ertl G; Bijnens B; Weidemann F
J Hypertens; 2009 Dec; 27(12):2483-91. PubMed ID: 19887955
[TBL] [Abstract][Full Text] [Related]
15. Amino-terminal pro-brain natriuretic peptide predicts ventricular arrhythmogenesis in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillators.
Manios EG; Kallergis EM; Kanoupakis EM; Mavrakis HE; Kambouraki DC; Arfanakis DA; Vardas PE
Chest; 2005 Oct; 128(4):2604-10. PubMed ID: 16236931
[TBL] [Abstract][Full Text] [Related]
16. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
[TBL] [Abstract][Full Text] [Related]
17. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.
López B; González A; Querejeta R; Larman M; Díez J
J Am Coll Cardiol; 2006 Jul; 48(1):89-96. PubMed ID: 16814653
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of biomarkers of collagen synthesis and ventricular function and dyssynchrony in adolescents and young adults after repair of tetralogy of Fallot.
Lai CT; Chan KW; Wong SJ; Chow PC; Cheung YF
Am Heart J; 2011 Sep; 162(3):467-73. PubMed ID: 21884862
[TBL] [Abstract][Full Text] [Related]
20. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
